Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism

NCT01360996 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Ovary Syndrome

Interventions

DRUG: 3 mg DRSP/20 μg EE

Sponsor

Woman's

Collaborators

[object Object]